![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
CLINIC-LEVEL FACTORS ASSOCIATED WITH TIME TO
VIRAL SUPPRESSION IN WASHINGTON DC
|
|
|
Reported by Jules Levin
CROI 2018
Monroe AK1, Rayeed N2, Jaurretche M1, Powers Happ L1, Trac K1, TerzianA1, Greenberg AE1, Castel AD1, on behalf of the DC Cohort Executive Committee
1 Milken Institute School of Public Health of the George Washington University, Washington, DC 2 Cerner Corporation, Kansas City, MO
![0724181](../images%20/072418/072418-1/0724181.gif)
![0724182](../images%20/072418/072418-1/0724182.gif)
![0724183](../images%20/072418/072418-1/0724183.gif)
![0724184](../images%20/072418/072418-1/0724184.gif)
![0724185](../images%20/072418/072418-1/0724185.gif)
![0724186](../images%20/072418/072418-1/0724186.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|